Pankaj Malhotra

ORCID: 0009-0004-2849-832X · 2 papers in corpus

article 2025

Danazol causes significant changes in the cardiometabolic profile of patients with acquired aplastic anaemia

·doi:10.1016/j.bcmd.2025.102921

BackgroundDanazol is frequently used in treating patients with acquired aplastic anaemia (AA) in resource-constraint settings. We aimed to evaluate the cardiometabolic side effects of Danazol in patients with AA.MethodsThis prospective stud…

article 2018

Danazol increases T regulatory cells in patients with aplastic anemia

·doi:10.1080/10245332.2018.1435045

OBJECTIVES: FoxP3+ T regulatory cells (T-regs) in the pathophysiology of AA and their response to treatment with Danazol alone or in combination with immunosuppressive treatment (IST). METHODS: T-regs' percentages of 25 acquired idiopathic …